Perceptive Inc. published a blog exploring how PET, SPECT, MRI, and optical imaging support better-informed decisions from discovery through IND-enabling studies.
Published
Signal category
Research & Knowledge
Quote
“Our latest blog explores how PET, SPECT, MRI and optical imaging can support better-informed decisions from discovery through IND-enabling studies.”
— Laurie Mahns|Perceptive Inc. team
Company
Perceptive Inc.
Delivering Discovery, eClinical, and Imaging Solutions to the Global Biopharmaceutical Industry
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 1,290 employees
Expanding on their combined 50-year history, Perceptive provides best-in-class specialist support to global pharmaceutical, biotech, and clinical research organizations, spanning the complete R&D lifecycle, from discovery and preclinical through clinical development to post marketing. Perceptive’s offerings include imaging biomarkers and core lab services, as well as innovative technologies in randomization and trial supply management (RTSM), analytics, and software.